Roche Holding AG said an experimental breast-cancer treatment will get an expedited review from US regulators after showing it helped patients live longer without the disease progressing. The ...

Priority Review recognises the best-in-class potential of the inavolisib-based regimen for patients in urgent need of new treatment options 1,2 Additional analyses of INAVO120 will be presented in ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

A Bristol Myers Squibb drug has got an FDA approval to treat tumors with a specific biomarker regardless of their locations ...

Last week, readers were most interested in a story about Roche's four-in-one molecular test receiving Emergency Use Authorization from the FDA.

Jennifer Garner and Ben Affleck's daughter Violet graduates: See the emotional reaction Peanuts by Charles Schulz We Ordered 7 Fast-Food Breakfast Sandwiches to Find the Best One 223 vs 556: What ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Benzinga - by Zacks, Benzinga Contributor. Roche (OTC: RHHBY) obtained a Breakthrough Therapy Designation for its investigational oral therapy inavolisib for treating adult breast cancer patients in ...